ID   LAT2_HUMAN              Reviewed;         535 AA.
AC   Q9UHI5; B2R8Q4; B4DKT4; B4DTV6; D3DS46; F2Z2J4; Q86U05; Q9UKQ6;
AC   Q9UKQ7; Q9UKQ8; Q9Y445;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   15-MAR-2017, entry version 155.
DE   RecName: Full=Large neutral amino acids transporter small subunit 2;
DE   AltName: Full=L-type amino acid transporter 2;
DE            Short=hLAT2;
DE   AltName: Full=Solute carrier family 7 member 8;
GN   Name=SLC7A8; Synonyms=LAT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBUNIT, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   INHIBITION.
RX   PubMed=10391915; DOI=10.1074/jbc.274.28.19738;
RA   Pineda M., Fernandez E., Torrents D., Estevez R., Lopez C., Camps M.,
RA   Lloberas J., Zorzano A., Palacin M.;
RT   "Identification of a membrane protein, LAT-2, that co-expresses with
RT   4F2 heavy chain, an L-type amino acid transport activity with broad
RT   specificity for small and large zwitterionic amino acids.";
RL   J. Biol. Chem. 274:19738-19744(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND SUBUNIT.
RC   TISSUE=Melanocyte;
RX   PubMed=10574970; DOI=10.1074/jbc.274.49.34948;
RA   Rossier G., Meier C., Bauch C., Summa V., Sordat B., Verrey F.,
RA   Kuehn L.C.;
RT   "LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter
RT   of kidney and intestine.";
RL   J. Biol. Chem. 274:34948-34954(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=10080183; DOI=10.1038/6815;
RA   Borsani G., Bassi M.T., Sperandeo M.P., De Grandi A., Buoninconti A.,
RA   Riboni M., Manzoni M., Incerti B., Pepe A., Andria G., Ballabio A.,
RA   Sebastio G.;
RT   "SLC7A7, encoding a putative permease-related protein, is mutated in
RT   patients with lysinuric protein intolerance.";
RL   Nat. Genet. 21:297-301(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBUNIT, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   INHIBITION.
RC   TISSUE=Kidney;
RX   PubMed=15918515; DOI=10.1007/BF02977671;
RA   Park S.Y., Kim J.-K., Kim I.J., Choi B.K., Jung K.Y., Lee S.,
RA   Park K.J., Chairoungdua A., Kanai Y., Endou H., Kim D.K.;
RT   "Reabsorption of neutral amino acids mediated by amino acid
RT   transporter LAT2 and TAT1 in the basolateral membrane of proximal
RT   tubule.";
RL   Arch. Pharm. Res. 28:421-432(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Hippocampus, Placenta, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=11311135;
RA   Broeer A., Friedrich B., Wagner C.A., Fillon S., Ganapathy V.,
RA   Lang F., Broeer S.;
RT   "Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires
RT   different domains.";
RL   Biochem. J. 355:725-731(2001).
RN   [11]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND INHIBITION.
RX   PubMed=12117417; DOI=10.1042/BJ20020841;
RA   Simmons-Willis T.A., Koh A.S., Clarkson T.W., Ballatori N.;
RT   "Transport of a neurotoxicant by molecular mimicry: the methylmercury-
RT   L-cysteine complex is a substrate for human L-type large neutral amino
RT   acid transporter (LAT) 1 and LAT2.";
RL   Biochem. J. 367:239-246(2002).
RN   [12]
RP   FUNCTION, SUBUNIT, AND INDUCTION.
RX   PubMed=12716892; DOI=10.1074/jbc.M302777200;
RA   Liu X., Charrier L., Gewirtz A., Sitaraman S., Merlin D.;
RT   "CD98 and intracellular adhesion molecule I regulate the activity of
RT   amino acid transporter LAT-2 in polarized intestinal epithelia.";
RL   J. Biol. Chem. 278:23672-23677(2003).
RN   [13]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, AND
RP   INHIBITION.
RX   PubMed=15081149; DOI=10.1016/j.ijpharm.2004.01.035;
RA   Gandhi M.D., Pal D., Mitra A.K.;
RT   "Identification and functional characterization of a Na(+)-independent
RT   large neutral amino acid transporter (LAT2) on ARPE-19 cells.";
RL   Int. J. Pharm. 275:189-200(2004).
RN   [14]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16027961; DOI=10.1007/s00726-005-0221-x;
RA   Fraga S., Pinho M.J., Soares-da-Silva P.;
RT   "Expression of LAT1 and LAT2 amino acid transporters in human and rat
RT   intestinal epithelial cells.";
RL   Amino Acids 29:229-233(2005).
RN   [15]
RP   FUNCTION, SUBUNIT, AND INHIBITION.
RX   PubMed=15769744; DOI=10.1074/jbc.M413164200;
RA   Li S., Whorton A.R.;
RT   "Identification of stereoselective transporters for S-nitroso-L-
RT   cysteine: role of LAT1 and LAT2 in biological activity of S-
RT   nitrosothiols.";
RL   J. Biol. Chem. 280:20102-20110(2005).
CC   -!- FUNCTION: Sodium-independent, high-affinity transport of small and
CC       large neutral amino acids such as alanine, serine, threonine,
CC       cysteine, phenylalanine, tyrosine, leucine, arginine and
CC       tryptophan, when associated with SLC3A2/4F2hc. Acts as an amino
CC       acid exchanger. Has higher affinity for L-phenylalanine than LAT1
CC       but lower affinity for glutamine and serine. L-alanine is
CC       transported at physiological concentrations. Plays a role in
CC       basolateral (re)absorption of neutral amino acids. Involved in the
CC       uptake of methylmercury (MeHg) when administered as the L-cysteine
CC       or D,L-homocysteine complexes, and hence plays a role in metal ion
CC       homeostasis and toxicity. Involved in the cellular activity of
CC       small molecular weight nitrosothiols, via the stereoselective
CC       transport of L-nitrosocysteine (L-CNSO) across the transmembrane.
CC       Plays an essential role in the reabsorption of neutral amino acids
CC       from the epithelial cells to the bloodstream in the kidney.
CC       {ECO:0000269|PubMed:10391915, ECO:0000269|PubMed:10574970,
CC       ECO:0000269|PubMed:11311135, ECO:0000269|PubMed:12117417,
CC       ECO:0000269|PubMed:12716892, ECO:0000269|PubMed:15081149,
CC       ECO:0000269|PubMed:15769744, ECO:0000269|PubMed:15918515}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=221 uM for L-leucine {ECO:0000269|PubMed:10391915,
CC         ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149,
CC         ECO:0000269|PubMed:15918515};
CC         KM=64 uM for MeHg-L-cysteine {ECO:0000269|PubMed:10391915,
CC         ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149,
CC         ECO:0000269|PubMed:15918515};
CC         KM=161 uM for methionine {ECO:0000269|PubMed:10391915,
CC         ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149,
CC         ECO:0000269|PubMed:15918515};
CC         KM=978 uM for L-alanine {ECO:0000269|PubMed:10391915,
CC         ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149,
CC         ECO:0000269|PubMed:15918515};
CC         KM=89.35 uM for L-phenylalanine {ECO:0000269|PubMed:10391915,
CC         ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149,
CC         ECO:0000269|PubMed:15918515};
CC         KM=57.3 uM for L-tryptophan {ECO:0000269|PubMed:10391915,
CC         ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149,
CC         ECO:0000269|PubMed:15918515};
CC         KM=48.8 uM for L-tyrosine {ECO:0000269|PubMed:10391915,
CC         ECO:0000269|PubMed:12117417, ECO:0000269|PubMed:15081149,
CC         ECO:0000269|PubMed:15918515};
CC   -!- SUBUNIT: Disulfide-linked heterodimer with the amino acid
CC       transport protein SLC3A2/4F2hc. {ECO:0000269|PubMed:10391915,
CC       ECO:0000269|PubMed:10574970, ECO:0000269|PubMed:11311135,
CC       ECO:0000269|PubMed:12716892, ECO:0000269|PubMed:15769744,
CC       ECO:0000269|PubMed:15918515}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Basolateral cell membrane; Multi-
CC       pass membrane protein. Note=Localized to the cytoplasm when
CC       expressed alone but when coexpressed with SLC3A2/4F2hc, is
CC       localized to the plasma membrane. Colocalized with SLC3A2/4F2hc at
CC       the basolateral membrane of kidney cortex proximal tubules and
CC       small intestine epithelia of the villi.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9UHI5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UHI5-2; Sequence=VSP_046946;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9UHI5-3; Sequence=VSP_046945;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q9UHI5-4; Sequence=VSP_046947;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Strongest expression is observed in kidney and
CC       moderate expression in placenta and brain, followed by liver,
CC       prostate, testis, ovary, lymph node, thymus, spleen, skeletal
CC       muscle and heart. Also expressed in fetal liver as well as in the
CC       retinal pigment epithelial cell line ARPE-19 and the intestinal
CC       epithelial cell line Caco-2. {ECO:0000269|PubMed:10391915,
CC       ECO:0000269|PubMed:15081149, ECO:0000269|PubMed:15918515,
CC       ECO:0000269|PubMed:16027961}.
CC   -!- INDUCTION: Activity in polarized intestinal cells is regulated by
CC       the association between SLC3A2/4F2 (in the SLC3A2/4F2-LAT2
CC       heterodimer) and ICAM1. {ECO:0000269|PubMed:12716892}.
CC   -!- MISCELLANEOUS: L-leucine transport activity inhibited by small
CC       zwitterionic amino acids (i.e. glycine, alanine, serine, threonine
CC       asparginine, glutamine, methionine, leucine, isoleucine, valine,
CC       phenylalanine, tyrosine, tryptophan, histidine and cysteine) and
CC       by glutamine and asparginine. Methionine uptake was inhibited by
CC       the L-system substrates L-leucine, 2-amino-bicyclo-(2,2,1)-
CC       heptane-2-carboxylate (BCH), L-cysteine and by the MeHg-L-cysteine
CC       complex and structurally related S-ethyl-L-cysteine. MeHg-L-
CC       cysteine uptake is inhibited by L-methionine, L-leucine, BCH and
CC       S-ethyl-L-cysteine. L-leucine uptake was inhibited by L-CNSO.
CC   -!- SIMILARITY: Belongs to the amino acid-polyamine-organocation (APC)
CC       superfamily. L-type amino acid transporter (LAT) (TC 2.A.3.8)
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD62616.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF135828; AAF05695.1; -; mRNA.
DR   EMBL; AF135829; AAF05696.1; -; mRNA.
DR   EMBL; AF135830; AAF05697.1; -; mRNA.
DR   EMBL; AF171669; AAF20381.1; -; mRNA.
DR   EMBL; Y18483; CAB40137.1; -; mRNA.
DR   EMBL; AB037669; BAB21519.1; -; mRNA.
DR   EMBL; BX248288; CAD62616.1; ALT_INIT; mRNA.
DR   EMBL; AK296702; BAG59296.1; -; mRNA.
DR   EMBL; AK300384; BAG62118.1; -; mRNA.
DR   EMBL; AK313465; BAG36251.1; -; mRNA.
DR   EMBL; AL117258; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471078; EAW66181.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW66182.1; -; Genomic_DNA.
DR   EMBL; BC052250; AAH52250.1; -; mRNA.
DR   CCDS; CCDS41924.1; -. [Q9UHI5-2]
DR   CCDS; CCDS58304.1; -. [Q9UHI5-3]
DR   CCDS; CCDS58305.1; -. [Q9UHI5-4]
DR   CCDS; CCDS9590.1; -. [Q9UHI5-1]
DR   RefSeq; NP_001253965.1; NM_001267036.1. [Q9UHI5-4]
DR   RefSeq; NP_001253966.1; NM_001267037.1. [Q9UHI5-3]
DR   RefSeq; NP_036376.2; NM_012244.3. [Q9UHI5-1]
DR   RefSeq; NP_877392.1; NM_182728.2. [Q9UHI5-2]
DR   UniGene; Hs.596643; -.
DR   ProteinModelPortal; Q9UHI5; -.
DR   BioGrid; 116996; 1.
DR   IntAct; Q9UHI5; 1.
DR   STRING; 9606.ENSP00000320378; -.
DR   DrugBank; DB00160; L-Alanine.
DR   DrugBank; DB00130; L-Glutamine.
DR   DrugBank; DB00120; L-Phenylalanine.
DR   DrugBank; DB01235; Levodopa.
DR   DrugBank; DB02750; S-(Methylmercury)-L-Cysteine.
DR   TCDB; 2.A.3.8.20; the amino acid-polyamine-organocation (apc) family.
DR   iPTMnet; Q9UHI5; -.
DR   PhosphoSitePlus; Q9UHI5; -.
DR   SwissPalm; Q9UHI5; -.
DR   BioMuta; SLC7A8; -.
DR   DMDM; 12643348; -.
DR   EPD; Q9UHI5; -.
DR   PaxDb; Q9UHI5; -.
DR   PeptideAtlas; Q9UHI5; -.
DR   PRIDE; Q9UHI5; -.
DR   Ensembl; ENST00000316902; ENSP00000320378; ENSG00000092068. [Q9UHI5-1]
DR   Ensembl; ENST00000422941; ENSP00000416398; ENSG00000092068. [Q9UHI5-3]
DR   Ensembl; ENST00000453702; ENSP00000391577; ENSG00000092068. [Q9UHI5-2]
DR   Ensembl; ENST00000529705; ENSP00000434345; ENSG00000092068. [Q9UHI5-4]
DR   GeneID; 23428; -.
DR   KEGG; hsa:23428; -.
DR   UCSC; uc001wix.5; human. [Q9UHI5-1]
DR   CTD; 23428; -.
DR   DisGeNET; 23428; -.
DR   GeneCards; SLC7A8; -.
DR   HGNC; HGNC:11066; SLC7A8.
DR   HPA; CAB046015; -.
DR   HPA; HPA051950; -.
DR   HPA; HPA060672; -.
DR   MIM; 604235; gene.
DR   neXtProt; NX_Q9UHI5; -.
DR   OpenTargets; ENSG00000092068; -.
DR   PharmGKB; PA35926; -.
DR   eggNOG; KOG1287; Eukaryota.
DR   eggNOG; COG0531; LUCA.
DR   GeneTree; ENSGT00760000119037; -.
DR   HOGENOM; HOG000098892; -.
DR   HOVERGEN; HBG000476; -.
DR   InParanoid; Q9UHI5; -.
DR   KO; K13781; -.
DR   OMA; PALYIVM; -.
DR   OrthoDB; EOG091G07EM; -.
DR   PhylomeDB; Q9UHI5; -.
DR   TreeFam; TF313355; -.
DR   BioCyc; MetaCyc:ENSG00000092068-MONOMER; -.
DR   Reactome; R-HSA-210991; Basigin interactions.
DR   Reactome; R-HSA-352230; Amino acid transport across the plasma membrane.
DR   SABIO-RK; Q9UHI5; -.
DR   ChiTaRS; SLC7A8; human.
DR   GeneWiki; SLC7A8; -.
DR   GenomeRNAi; 23428; -.
DR   PRO; PR:Q9UHI5; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000092068; -.
DR   CleanEx; HS_LAT2; -.
DR   CleanEx; HS_SLC7A8; -.
DR   ExpressionAtlas; Q9UHI5; baseline and differential.
DR   Genevisible; Q9UHI5; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0015171; F:amino acid transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015297; F:antiporter activity; IBA:GO_Central.
DR   GO; GO:0015179; F:L-amino acid transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015175; F:neutral amino acid transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0015101; F:organic cation transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0019534; F:toxin transporter activity; IDA:UniProtKB.
DR   GO; GO:0006865; P:amino acid transport; IDA:UniProtKB.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; TAS:ProtInc.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0055065; P:metal ion homeostasis; NAS:UniProtKB.
DR   GO; GO:0015804; P:neutral amino acid transport; ISS:UniProtKB.
DR   GO; GO:0009636; P:response to toxic substance; NAS:UniProtKB.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR002293; AA/rel_permease1.
DR   InterPro; IPR004760; L_AA_transporter.
DR   Pfam; PF13520; AA_permease_2; 1.
DR   PIRSF; PIRSF006060; AA_transporter; 1.
DR   TIGRFAMs; TIGR00911; 2A0308; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Amino-acid transport; Cell membrane;
KW   Complete proteome; Cytoplasm; Disulfide bond; Membrane;
KW   Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    535       Large neutral amino acids transporter
FT                                small subunit 2.
FT                                /FTId=PRO_0000054273.
FT   TRANSMEM     40     60       Helical. {ECO:0000255}.
FT   TRANSMEM     72     92       Helical. {ECO:0000255}.
FT   TRANSMEM    113    133       Helical. {ECO:0000255}.
FT   TRANSMEM    155    175       Helical. {ECO:0000255}.
FT   TRANSMEM    189    209       Helical. {ECO:0000255}.
FT   TRANSMEM    231    251       Helical. {ECO:0000255}.
FT   TRANSMEM    268    288       Helical. {ECO:0000255}.
FT   TRANSMEM    310    330       Helical. {ECO:0000255}.
FT   TRANSMEM    362    382       Helical. {ECO:0000255}.
FT   TRANSMEM    388    408       Helical. {ECO:0000255}.
FT   TRANSMEM    424    444       Helical. {ECO:0000255}.
FT   TRANSMEM    447    467       Helical. {ECO:0000255}.
FT   MOD_RES      29     29       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9QXW9}.
FT   VAR_SEQ       1    263       MEEGARHRNNTEKKHPGGGESDASPEAGSGGGGVALKKEIG
FT                                LVSACGIIVGNIIGSGIFVSPKGVLENAGSVGLALIVWIVT
FT                                GFITVVGALCYAELGVTIPKSGGDYSYVKDIFGGLAGFLRL
FT                                WIAVLVIYPTNQAVIALTFSNYVLQPLFPTCFPPESGLRLL
FT                                AAICLLLLTWVNCSSVRWATRVQDIFTAGKLLALALIIIMG
FT                                IVQICKGEYFWLEPKNAFENFQEPDIGLVALAFLQGSFAYG
FT                                GWNFLNYVTEELVDPYK -> MGQLFQCAVGHPGSRHLHSW
FT                                EAPGLGPDYHHGDCTDMQR (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046945.
FT   VAR_SEQ       1    203       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_046946.
FT   VAR_SEQ       1    169       MEEGARHRNNTEKKHPGGGESDASPEAGSGGGGVALKKEIG
FT                                LVSACGIIVGNIIGSGIFVSPKGVLENAGSVGLALIVWIVT
FT                                GFITVVGALCYAELGVTIPKSGGDYSYVKDIFGGLAGFLRL
FT                                WIAVLVIYPTNQAVIALTFSNYVLQPLFPTCFPPESGLRLL
FT                                AAICL -> MGQYGQELSWKCLVKAVCLQEHSQPSQLLCTL
FT                                LLCWCVLGRERPFRKAQSTSSPLEGVPRFLKR (in
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046947.
FT   CONFLICT    225    225       N -> D (in Ref. 3; CAB40137).
FT                                {ECO:0000305}.
FT   CONFLICT    401    401       V -> G (in Ref. 3; CAB40137).
FT                                {ECO:0000305}.
FT   CONFLICT    503    503       G -> R (in Ref. 1; AAF05696/AAF05697).
FT                                {ECO:0000305}.
SQ   SEQUENCE   535 AA;  58382 MW;  AC129146353F1E47 CRC64;
     MEEGARHRNN TEKKHPGGGE SDASPEAGSG GGGVALKKEI GLVSACGIIV GNIIGSGIFV
     SPKGVLENAG SVGLALIVWI VTGFITVVGA LCYAELGVTI PKSGGDYSYV KDIFGGLAGF
     LRLWIAVLVI YPTNQAVIAL TFSNYVLQPL FPTCFPPESG LRLLAAICLL LLTWVNCSSV
     RWATRVQDIF TAGKLLALAL IIIMGIVQIC KGEYFWLEPK NAFENFQEPD IGLVALAFLQ
     GSFAYGGWNF LNYVTEELVD PYKNLPRAIF ISIPLVTFVY VFANVAYVTA MSPQELLASN
     AVAVTFGEKL LGVMAWIMPI SVALSTFGGV NGSLFTSSRL FFAGAREGHL PSVLAMIHVK
     RCTPIPALLF TCISTLLMLV TSDMYTLINY VGFINYLFYG VTVAGQIVLR WKKPDIPRPI
     KINLLFPIIY LLFWAFLLVF SLWSEPVVCG IGLAIMLTGV PVYFLGVYWQ HKPKCFSDFI
     ELLTLVSQKM CVVVYPEVER GSGTEEANED MEEQQQPMYQ PTPTKDKDVA GQPQP
//
